Literature DB >> 361035

Characterization of pepsin-solubilized bovine heart-valve collagen.

R I Bashey, H M Bashey, S A Jimenez.   

Abstract

Collagens extracted from heart valves by using limited pepsin digestion were fractionated by differential salt precipitation. Collagen types were identified by sodium dodecyl sulphate/polyacrylamide-gel electrophoresis, amino acid analysis and cleavage with CNBr. Heart-valve collagen was heterogeneous in nature, consisting of a mixture of type-I and type-III collagens. The identity of type-III collagen was established on the basis of (a) insolubility in 1.7 M-NaC1 at neutral pH, (b) behaviour of this collagen fraction on gel electrophoresis under reducing and non-reducing conditions, (c) amino acid analysis showing a hydroxyproline/proline ratio greater than 1, and (d) profile of CNBr peptides on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis showing a peak characteristic for type-III collagen containing peptides alpha1(III)CB8 and alpha1(III)CB3. In addition to types-I and -III collagen, a collagen polypeptide not previously described in heart valves was identified. This polypeptide represented approx. 30% of the collagen fraction precipitated at 4.0 M-NaCl, it migrated between beta- and alpha1-collagen chains on sodium dodecyl sulphate/polyacrylamide-gel electrophoresis and its electrophoretic behaviour was not affected by disulphide-bond reduction. All collagen fractions from the heart valves contained increased amounts of hydroxylysine when compared with type-I and -III collagens from other tissues. The presence of beta- and gamma-chains and higher aggregates in pepsin-solubilized collagen indicated that these collagens were highly cross-linked and suggested that some of these cross-links involved the triple-helical regions of the molecule. It is likely that the higher hydroxylysine content of heart-valve collagen is responsible for the high degree of intermolecular cross-linking and may be the result of an adaptive mechanism for the specialized function of these tissues.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361035      PMCID: PMC1185855          DOI: 10.1042/bj1730885

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

Authors:  J F WOESSNER
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

2.  Biochemical characteristics and biological significance of the genetically-distinct collagens.

Authors:  E J Miller
Journal:  Mol Cell Biochem       Date:  1976-12-10       Impact factor: 3.396

3.  The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis.

Authors:  P G Scott; A Veis
Journal:  Connect Tissue Res       Date:  1976       Impact factor: 3.417

4.  Collagen fractionation: separation of native types I, II and III by differential precipitation.

Authors:  R L Trelstad; V M Catanese; D F Rubin
Journal:  Anal Biochem       Date:  1976-03       Impact factor: 3.365

5.  The collagen of heart valve.

Authors:  D Collins; K Lindberg; B McLees; S Pinnell
Journal:  Biochim Biophys Acta       Date:  1977-11-25

6.  Decreased thermal stability of collagens containing analogs of proline or lysine.

Authors:  S Jimenez; J Rosenbloom
Journal:  Arch Biochem Biophys       Date:  1974-08       Impact factor: 4.013

7.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

8.  Human aorta collagens: evidence for three distinct species.

Authors:  R L Trelstad
Journal:  Biochem Biophys Res Commun       Date:  1974-04-08       Impact factor: 3.575

9.  The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis.

Authors:  P D Benya; S R Padilla; M E Nimni
Journal:  Biochemistry       Date:  1977-03-08       Impact factor: 3.162

10.  The cyanogen bromide peptides of bovine soluble and insoluble collagens. II. Tissue specific cross-linked peptides of insoluble skin and dentin collagen.

Authors:  P G Scott; A Veis
Journal:  Connect Tissue Res       Date:  1976       Impact factor: 3.417

View more
  6 in total

Review 1.  The impairment of lysyl oxidase in keratoconus and in keratoconus-associated disorders.

Authors:  Lubica Dudakova; Katerina Jirsova
Journal:  J Neural Transm (Vienna)       Date:  2013-02-20       Impact factor: 3.575

2.  Prevalence of mitral valve prolapse in keratoconus patients.

Authors:  K W Sharif; T A Casey; J Coltart
Journal:  J R Soc Med       Date:  1992-08       Impact factor: 5.344

3.  Extracellular matrix of porcine pericardium: biochemistry and collagen architecture.

Authors:  Antonella Sachsida Braga-Vilela; Edson Rosa Pimentel; Sergio Marangoni; Marcos Hikari Toyama; Benedicto de Campos Vidal
Journal:  J Membr Biol       Date:  2007-12-03       Impact factor: 1.843

4.  Impaired corneal biomechanical properties and the prevalence of keratoconus in mitral valve prolapse.

Authors:  Emine Kalkan Akcay; Murat Akcay; Betul Seher Uysal; Pinar Kosekahya; Abdullah Nabi Aslan; Mehtap Caglayan; Cemal Koseoglu; Fatma Yulek; Nurullah Cagil
Journal:  J Ophthalmol       Date:  2014-04-17       Impact factor: 1.909

5.  Risk of Mitral Valve Prolapse in Patients with Keratoconus in Taiwan: A Population-Based Cohort Study.

Authors:  Yuh-Shin Chang; Ming-Cheng Tai; Shih-Feng Weng; Jhi-Joung Wang; Sung-Huei Tseng; Ren-Long Jan
Journal:  Int J Environ Res Public Health       Date:  2020-08-20       Impact factor: 3.390

6.  Physical equivalency of wild type and galactose α 1,3 galactose free porcine pericardium; a new source material for bioprosthetic heart valves.

Authors:  Christopher McGregor; Guerard Byrne; Benyamin Rahmani; Elisa Chisari; Konstantina Kyriakopoulou; Gaetano Burriesci
Journal:  Acta Biomater       Date:  2016-06-04       Impact factor: 8.947

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.